AVR-RD-01

N/A

Report date: 2023/01/12 15:52:03

Base Information

Drug NameAVR-RD-01
Drug Alias NameAVR-02AVR-RD-01
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionCell replacementsGene transferenceα-Galactosidase stimulants
Targetsα-Galactosidase
Therapy Area/IndicationsFabry Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesAustralia +[4] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAvrobio
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Health Network (Uhn)
Inactive CompaniesAvrobio
Active IndicationsFabry Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A